Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

What we have learned about the role of 17-alpha-hydroxyprogesterone caproate in the prevention of preterm birth.

Caritis SN, Feghali MN, Grobman WA, Rouse DJ; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network.

Semin Perinatol. 2016 Aug;40(5):273-80. doi: 10.1053/j.semperi.2016.03.002. Epub 2016 Apr 19. Review.

PMID:
27105940
2.

Bridging progestogens in pregnancy and pregnancy prevention.

Micks E, Raglan GB, Schulkin J.

Endocr Connect. 2015 Dec;4(4):R81-92. doi: 10.1530/EC-15-0093. Review.

3.

Vaginal progesterone, but not 17α-hydroxyprogesterone caproate, has antiinflammatory effects at the murine maternal-fetal interface.

Furcron AE, Romero R, Plazyo O, Unkel R, Xu Y, Hassan SS, Chaemsaithong P, Mahajan A, Gomez-Lopez N.

Am J Obstet Gynecol. 2015 Dec;213(6):846.e1-846.e19. doi: 10.1016/j.ajog.2015.08.010. Epub 2015 Aug 8.

4.

Recent advances in the prevention and management of preterm birth.

Tan MY, To M.

F1000Prime Rep. 2015 Apr 2;7:40. doi: 10.12703/P7-40. eCollection 2015. Review.

5.

Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations.

Feghali M, Venkataramanan R, Caritis S.

Semin Perinatol. 2014 Dec;38(8):516-22. doi: 10.1053/j.semperi.2014.08.013. Epub 2014 Sep 23. Review.

6.

Progesterone to prevent spontaneous preterm birth.

Romero R, Yeo L, Chaemsaithong P, Chaiworapongsa T, Hassan SS.

Semin Fetal Neonatal Med. 2014 Feb;19(1):15-26. doi: 10.1016/j.siny.2013.10.004. Epub 2013 Dec 5. Review.

7.

Critical appraisal of the efficacy, safety, and patient acceptability of hydroxyprogesterone caproate injection to reduce the risk of preterm birth.

Vidaeff AC, Belfort MA.

Patient Prefer Adherence. 2013 Jul 11;7:683-91. doi: 10.2147/PPA.S35612. Print 2013.

8.

Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice.

Romero R, Stanczyk FZ.

Am J Obstet Gynecol. 2013 Jun;208(6):421-6. doi: 10.1016/j.ajog.2013.04.027. Epub 2013 Apr 30. Review. No abstract available.

9.

A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix.

Romero R, Yeo L, Miranda J, Hassan SS, Conde-Agudelo A, Chaiworapongsa T.

J Perinat Med. 2013 Jan;41(1):27-44. doi: 10.1515/jpm-2012-0272. Review.

10.

Progesterone to prevent preterm birth in twin gestations: what is the next step forward?

Romero R.

BJOG. 2013 Jan;120(1):1-4. doi: 10.1111/1471-0528.12019. No abstract available.

11.

Progestogens to prevent preterm birth in twin pregnancies: an individual participant data meta-analysis of randomized trials.

Schuit E, Stock S, Groenwold RH, Maurel K, Combs CA, Garite T, Spong CY, Thom EA, Rouse DJ, Caritis SN, Saade GR, Zachary JM, Norman JE, Rode L, Klein K, Tabor A, Cetingöz E, Morrison JC, Magann EF, Briery CM, Serra V, Perales A, Meseguer J, Nassar AH, Lim AC, Moons KG, Kwee A, Mol BW.

BMC Pregnancy Childbirth. 2012 Mar 15;12:13. doi: 10.1186/1471-2393-12-13.

12.

17-Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trial.

Combs CA, Garite TJ, Maurel K, Mallory K, Edwards RK, Lu G, Porreco R, Das A; Obstetrix Collaborative Research Network.

BMC Res Notes. 2011 Dec 29;4:568. doi: 10.1186/1756-0500-4-568.

13.

Progesterone supplementation and the prevention of preterm birth.

Norwitz ER, Caughey AB.

Rev Obstet Gynecol. 2011 Summer;4(2):60-72.

14.

Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation.

Caritis SN, Sharma S, Venkataramanan R, Rouse DJ, Peaceman AM, Sciscione A, Spong CY, Varner MW, Malone FD, Iams JD, Mercer BM, Thorp JM Jr, Sorokin Y, Carpenter M, Lo J, Ramin S, Harper M; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

Am J Obstet Gynecol. 2011 Jul;205(1):40.e1-8. doi: 10.1016/j.ajog.2011.03.028. Epub 2011 Mar 22.

15.

Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birth.

Di Renzo GC, Roura LC, Facchinetti F, Antsaklis A, Breborowicz G, Gratacos E, Husslein P, Lamont R, Mikhailov A, Montenegro N, Radunovic N, Robson M, Robson SC, Sen C, Shennan A, Stamatian F, Ville Y.

J Matern Fetal Neonatal Med. 2011 May;24(5):659-67. doi: 10.3109/14767058.2011.553694. Epub 2011 Mar 2. No abstract available.

Supplemental Content

Support Center